Search Results

Men with rising PSA, who have undergone defnitive treatment (surgery, surgery with radiation, cryotherapy, radiation alone or brachytherapy) for the primary tumor and has a rising PSA at two time points each at least 1 week apart, higher then the previous reference value noted within 1 year of study entry. Patients with evidence of metastatic disease are not eligible, with the exception of positive lymph nodes at time of surgery or those less than 2cm that lack pathological confirmation would be eligible. Patient's with testosterone level greater than 150ng/mL at screening, age greater than 18 years old. Good ECOG Performace status 0,1,2. Use of herbal or dietary supplements must be stable 2 months prior to screening and the patient agrees to not stop or change the dose while on study. Adequate hepatic and renal function and normal electrolyte levels.